🕒 Monday 2 February 2026 Mon, 2 Feb 2026

Corporate Travel Management's founder Jamie Pherous retires, handing over leadership to Ana Pedersen as the company navigates accounting challenges and aims to relist on the ASX.

FortifAI Limited has completed its acquisition of FastAI Pty Ltd, gaining control of the innovative Nol8 technology and appointing seasoned executive Yosef Keret as director and Celerriem CEO.

North Stawell Minerals has announced key leadership changes, with Campbell Olsen stepping up as Non-Executive Chairman and Bill Reid joining as an Executive Director amid a critical growth phase.

Emyria Limited reports that approximately 67% of patients treated for PTSD remain in remission over 12 months post-treatment, highlighting the potential for lasting recovery and cost-effective care.

F.F.I. Holdings anticipates a modest decline in half-year profit, citing one-off lease expenses despite steady food operations.

CurveBeam AI has received the first A$4 million tranche of a planned A$10 million strategic investment from a leading Chinese orthopaedic device company, marking a significant step in its expansion into the Chinese market.

Adavale Resources has raised $5.15 million in a strongly supported placement to fund an expanded drilling program at its London Victoria Gold Mine and advance regional exploration efforts.

West Wits Mining has announced a substantial 44% increase in its gold resource at the Witwatersrand Basin Project, boosting the total to 7.24 million ounces and setting the stage for imminent production at Qala Shallows.

Genetic Signatures has appointed Maria Halasz as its new CEO, bringing over two decades of leadership in life sciences and capital markets to steer the company’s global expansion.

Pivotal Metals has revealed ore sorting test results at its Horden Lake project that deliver up to a 2.1 times uplift in copper grade, promising substantial cost savings and flexible development options in Quebec’s Tier 1 mining jurisdiction.

The Mozambique Government’s approval to restart the TotalEnergies-led LNG project has accelerated construction and workforce mobilisation, positioning RBR Group to capitalise on significant near-term opportunities.

Cluey Ltd has terminated its planned acquisition of Education Futures Group, the parent of Art of Smart, citing unmet conditions. The company remains focused on expanding its blended learning offerings and exploring new acquisition opportunities.

Imagion Biosystems has submitted its Investigational New Drug application to the U.S. FDA for its MagSense® HER2 Imaging Agent, marking a pivotal step toward launching a Phase 2 clinical trial for breast cancer detection.

Patriot Resources has appointed mining engineer and finance expert Dominic Duggan as CEO to spearhead development of its high-grade silver and gold projects across Peru, Zambia, and Canada.

Brightstar Resources has successfully raised $180 million through a $175 million institutional placement and a $5 million share purchase plan, fully funding its Goldfields development and advancing the Sandstone project towards a final investment decision.

Fortuna Metals has confirmed significant high-grade rutile mineralisation across broad areas of its Mkanda project in Malawi, with 675 drill holes completed and assays pending for the majority. The discovery positions the company alongside a world-class deposit and taps into surging demand for titanium in robotics.

Orion Minerals has been selected for the prestigious 2026 BHP Xplor accelerator program, receiving US$500,000 in equity-free funding and access to BHP’s global expertise to advance its South African exploration projects.

GrainCorp has lowered its FY26 earnings guidance, citing persistent global oversupply and weak grain prices that are squeezing margins and volumes. The agribusiness is accelerating cost controls while maintaining a strong balance sheet to navigate these headwinds.

Orthocell Ltd reports steady progress in commercialising its nerve repair product Remplir in the US, with sales growth, expanded distributor networks, and manufacturing upgrades underpinning its path to profitability.

Argenica Therapeutics has won a crucial regulatory waiver from the European Medicines Agency, removing the need for paediatric trials for its stroke drug ARG-007 and clearing the way for faster adult market approval in Europe.

Strickland Metals has reported compelling new drilling results at its Gradina Deposit in Serbia, revealing strong gold and base metal mineralisation that extends beyond the existing 1.2 million ounce resource. These findings highlight significant growth potential within the Rogozna Project.

Recce Pharmaceuticals has secured a second Cooperative Research and Development Agreement with the U.S. Army Institute of Surgical Research to test its RECCE 327 Gel in burn wound infection models, underscoring growing military interest in its synthetic anti-infectives.

Arika Resources has agreed to acquire the remaining 20% stake in its flagship Yundamindra and Kookynie gold projects, consolidating full ownership and positioning itself for accelerated exploration in Western Australia’s prolific goldfields.

Barton Gold Holdings has initiated an 8,000m drilling campaign at its Challenger Gold Project, aiming to upgrade resources and deliver a Definitive Feasibility Study by mid-2026. This move sets the stage for restarting the Central Gawler Mill and advancing multiple regional assets.